Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6K Sell
14,228
-6,998
-33% -$11K ﹤0.01% 3845
2026
Q1
$29.7K Sell
21,226
-409
-2% -$525 ﹤0.01% 3454
2025
Q4
$25.1K Buy
+21,635
New +$34.8K ﹤0.01% 3015
2025
Q3
Sell
-4,331
Closed -$40.1K 2587
2025
Q2
$40.1K Buy
+4,331
New +$42.8K ﹤0.01% 2061
2023
Q3
Sell
-134
Closed -$57.7K 1574
2023
Q2
$57.7K Buy
+134
New +$90.3K 0.01% 1224

Other funds holding BIVI

XTX Topco's BIVI Position: Q2 2026 in Review

XTX Topco reduced its BioVie (BIVI) stake by 33% in Q2 2026, selling an estimated $11K and leaving 14,228 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3845.

XTX Topco first reported a position in BIVI in Q2 2023 and has held it in 5 quarters since. The position peaked at $57.7K in Q2 2023. 35 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • XTX Topco held 14,228 shares of BioVie worth $27.6K as of Q2 2026.
  • XTX Topco sold 6,998 BioVie shares in Q2 2026, an estimated $11K.
  • BioVie made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3845 holding.
  • XTX Topco first reported a position in BioVie in Q2 2023 and has held it in 5 quarters since.
  • XTX Topco's BioVie position peaked at $57.7K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.